Conatus Pharmaceuticals (CNAT) Earnings

Aug 7Confirmed
Nov 2018
Mar 2019
May 2019
Aug 2019
-0.15
-0.11
-0.06
-0.02

Details

Expected EPS
-0.12
Actual EPS
-0.02
Surprise EPS
0.1
Surprise Percent
+83.33%

Description

⁨Conatus Pharmaceuticals⁩ (⁦CNAT⁩) has reported earnings of ⁦-0.02⁩ per share for ⁦null⁩.

0 Comments

Share your thoughts